z-logo
Premium
Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune‐suppressive genes in regulatory T cells of generalized vitiligo patients
Author(s) -
Giri Prashant S.,
Dwivedi Mitesh,
Laddha Naresh C.,
Begum Rasheedunnisa,
Bharti Ankit H.
Publication year - 2020
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12862
Subject(s) - foxp3 , vitiligo , pathogenesis , immune system , immunology , medicine , il 2 receptor , interleukin 10 , biology , endocrinology , cancer research , t cell
The study was aimed to analyze expression of nuclear factor of activated T cells ( NFATs ), forkhead box P3 ( FOXP3), and their associated genes (s CTLA4, flCTLA4, IL10, TGFB, IL2, IL4, CD25) in regulatory T cells (Tregs) of 48 generalized vitiligo (GV) patients and 45 unaffected controls. The transcripts of NFATC1 to NFATC4, FOXP3, IL10, flCTLA4 ( p  < .0001), NFAT5 ( p  = .0003), sCTLA4 ( p  = .001), and FOXP3 protein in Tregs and plasma IL‐10 levels were reduced significantly ( p  < .0001) in GV Tregs compared to controls. The FOXP3 promoter polymorphisms [rs3761548(C > A), rs3761547(A > G), and rs2232365(A > G)] revealed significantly decreased FOXP3 protein levels in patients' Tregs with susceptible AA, GG, and GG genotypes ( p  < .0001, p  = .028, p  = .022, respectively). The active vitiligo Tregs showed reduced levels of NFATC3, NFATC4 , NFAT5, FOXP3, TGFB, and flCTLA4 transcripts ( p  = .0005, p  = .0003, p  = .0002, p  = .020, p  < .0001, p  = .006, respectively) and FOXP3 and TGF‐β proteins ( p  = .0394 and p  = .0013) compared to stable vitiligo. Early‐onset patients (1–20 years) demonstrated decreased IL‐10, sCTLA‐4, flCTLA‐4, TGFB, and FOXP3 transcripts and FOXP3 protein as compared to late‐onset patients (41–60 years) ( p  = .001, p  = .003, p  = .009, p  = .005, p  = .038, p  = .0226, respectively). Overall, our results for the first time suggest a likely role of NFATs and FOXP3 together with Treg immune‐suppressive genes in GV pathogenesis and disease progression, warranting additional investigations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here